Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Change in Receivables: 2022-2024

Historic Change in Receivables for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to -$22,000.

  • Orchestra BioMed Holdings' Change in Receivables fell 188.57% to -$31,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$78,000, marking a year-over-year decrease of 368.97%. This contributed to the annual value of -$22,000 for FY2024, which is 833.33% down from last year.
  • Orchestra BioMed Holdings' Change in Receivables amounted to -$22,000 in FY2024, which was down 833.33% from $3,000 recorded in FY2023.
  • Over the past 5 years, Orchestra BioMed Holdings' Change in Receivables peaked at $3,000 during FY2023, and registered a low of -$25,000 during FY2022.
  • In the last 3 years, Orchestra BioMed Holdings' Change in Receivables had a median value of -$22,000 in 2024 and averaged -$14,667.
  • As far as peak fluctuations go, Orchestra BioMed Holdings' Change in Receivables soared by 112.00% in 2023, and later tumbled by 833.33% in 2024.
  • Orchestra BioMed Holdings' Change in Receivables (Yearly) stood at -$25,000 in 2022, then spiked by 112.00% to $3,000 in 2023, then tumbled by 833.33% to -$22,000 in 2024.